Ocugen, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Mailing Address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Phone
484-328-4701
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$55.68M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| 8-K Current report of material events | March 20, 2026 | View on SEC |
| 3 Initial insider ownership report | March 5, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 10-K Annual financial report | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
Annual Reports
10-K
March 4, 2026
- Lead gene therapy OCU400 is in a Phase 3 clinical trial for Retinitis Pigmentosa, a gene-agnostic approach for various forms of the disease.
- OCU410 and OCU410ST are in a Phase 2/3 pivotal confirmatory trial for Stargardt disease, addressing another significant unmet medical need.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc.
PCVX
Biological Products, (No Diagnostic Substances)
RECURSION PHARMACEUTICALS, INC.
RXRX
Biological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc
MGTX
Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.